Three-Year Incidence of AIDS in Five Cohorts of HTLV-III-Infected Risk Group Members

The incidence of the acquired immune deficiency syndrome (AIDS) among persons infected with human T-lymphotropic virus type III (HTLV-III) was evaluated prospectively among 725 persons who were at high risk of AIDS and had enrolled before October 1982 in cohort studies of homosexual men, parenteral...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science (American Association for the Advancement of Science) 1986-02, Vol.231 (4741), p.992-995
Hauptverfasser: Goedert, James J., Biggar, Robert J., Weiss, Stanley H., Eyster, M. Elaine, Melbye, Mads, Wilson, Susan, Ginzburg, Harold M., Grossman, Ronald J., DiGioia, Richard A., Sanchez, William C., Giron, José A., Ebbesen, Peter, Gallo, Robert C., Blattner, William A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 995
container_issue 4741
container_start_page 992
container_title Science (American Association for the Advancement of Science)
container_volume 231
creator Goedert, James J.
Biggar, Robert J.
Weiss, Stanley H.
Eyster, M. Elaine
Melbye, Mads
Wilson, Susan
Ginzburg, Harold M.
Grossman, Ronald J.
DiGioia, Richard A.
Sanchez, William C.
Giron, José A.
Ebbesen, Peter
Gallo, Robert C.
Blattner, William A.
description The incidence of the acquired immune deficiency syndrome (AIDS) among persons infected with human T-lymphotropic virus type III (HTLV-III) was evaluated prospectively among 725 persons who were at high risk of AIDS and had enrolled before October 1982 in cohort studies of homosexual men, parenteral drug users, and hemophiliacs. A total of 276 (38.1 percent) of the subjects were either HTLV-III seropositive at enrollment or developed HTLV-III antibodies subsequently. AIDS had developed in 28 (10.1 percent) of the seropositive subjects before August 1985. By actuarial survival calculations, the 3-year incidence of AIDS among all HTLV-III seropositive subjects was 34.2 percent in the cohort of homosexual men in Manhattan, New York, and 14.9 percent (range 8.0 to 17.2 percent) in the four other cohorts. Out of 117 subjects followed for a mean of 31 months after documented seroconversion, five (all hemophiliacs) developed AIDS 28 to 62 months after the estimated date of seroconversion, supporting the hypothesis that there is a long latency between acquisition of viral infection and the development of clinical AIDS. This long latency could account for the significantly higher AIDS incidence in the New York cohort compared with other cohorts if the virus entered the New York homosexual population before it entered the populations from which the other cohorts were drawn. However, risk of AIDS development in different populations may also depend on the presence of as yet unidentified cofactors.
doi_str_mv 10.1126/science.3003917
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_76703359</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>1696964</jstor_id><sourcerecordid>1696964</sourcerecordid><originalsourceid>FETCH-LOGICAL-c407t-bc42309981cf20859b88dbba5c5969f0752b8a3a6fe2a768ffbfb9318c9a58963</originalsourceid><addsrcrecordid>eNqFkctrGzEQxkVpSJyk515aECXktokeu3ocg5vHgkMgdQs9LZI8IuvYK1faLeS_j4yXBHLxaWC-n74ZzYfQV0ouKGXiMrkWOgcXnBCuqfyEJpToqtCM8M9okpuiUERWR-g4pSUhWdP8EB2O-ATN508RoPgLJuK6c-1i64aDx1f1z1-47fBN-x_wNDyF2Kdt_24--1PUdV3UnQfXwwI_tukZ38YwbPA9rC3EdIoOvFkl-DLWE_T75no-vStmD7f19GpWuJLIvrCuZJxorajzjKhKW6UW1prKVVpon9dmVhluhAdmpFDeW281p8ppUykt-Ak63_luYvg3QOqbdZscrFamgzCkRgpJOM8_3gdywVQ-yH5HRqmsZFnuBWlZloIxmsEfH8BlGGKXz5LNeMWE1Fvocge5GFKK4JtNbNcmvjSUNNucmzHnZgwuv_g-2g52DYs3_l0_G3WTnFn5aHK46Q2TSklKeca-7bBl6kN8nypyAKLkr7n-tss</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>213526791</pqid></control><display><type>article</type><title>Three-Year Incidence of AIDS in Five Cohorts of HTLV-III-Infected Risk Group Members</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><source>American Association for the Advancement of Science</source><creator>Goedert, James J. ; Biggar, Robert J. ; Weiss, Stanley H. ; Eyster, M. Elaine ; Melbye, Mads ; Wilson, Susan ; Ginzburg, Harold M. ; Grossman, Ronald J. ; DiGioia, Richard A. ; Sanchez, William C. ; Giron, José A. ; Ebbesen, Peter ; Gallo, Robert C. ; Blattner, William A.</creator><creatorcontrib>Goedert, James J. ; Biggar, Robert J. ; Weiss, Stanley H. ; Eyster, M. Elaine ; Melbye, Mads ; Wilson, Susan ; Ginzburg, Harold M. ; Grossman, Ronald J. ; DiGioia, Richard A. ; Sanchez, William C. ; Giron, José A. ; Ebbesen, Peter ; Gallo, Robert C. ; Blattner, William A.</creatorcontrib><description>The incidence of the acquired immune deficiency syndrome (AIDS) among persons infected with human T-lymphotropic virus type III (HTLV-III) was evaluated prospectively among 725 persons who were at high risk of AIDS and had enrolled before October 1982 in cohort studies of homosexual men, parenteral drug users, and hemophiliacs. A total of 276 (38.1 percent) of the subjects were either HTLV-III seropositive at enrollment or developed HTLV-III antibodies subsequently. AIDS had developed in 28 (10.1 percent) of the seropositive subjects before August 1985. By actuarial survival calculations, the 3-year incidence of AIDS among all HTLV-III seropositive subjects was 34.2 percent in the cohort of homosexual men in Manhattan, New York, and 14.9 percent (range 8.0 to 17.2 percent) in the four other cohorts. Out of 117 subjects followed for a mean of 31 months after documented seroconversion, five (all hemophiliacs) developed AIDS 28 to 62 months after the estimated date of seroconversion, supporting the hypothesis that there is a long latency between acquisition of viral infection and the development of clinical AIDS. This long latency could account for the significantly higher AIDS incidence in the New York cohort compared with other cohorts if the virus entered the New York homosexual population before it entered the populations from which the other cohorts were drawn. However, risk of AIDS development in different populations may also depend on the presence of as yet unidentified cofactors.</description><identifier>ISSN: 0036-8075</identifier><identifier>EISSN: 1095-9203</identifier><identifier>DOI: 10.1126/science.3003917</identifier><identifier>PMID: 3003917</identifier><identifier>CODEN: SCIEAS</identifier><language>eng</language><publisher>Washington, DC: The American Association for the Advancement of Science</publisher><subject>Acquired immune deficiency syndrome ; Acquired Immunodeficiency Syndrome - microbiology ; Acquired Immunodeficiency Syndrome - physiopathology ; Acquired Immunodeficiency Syndrome - transmission ; AIDS ; AIDS/HIV ; Antibodies ; Antibodies, Viral - analysis ; Biological and medical sciences ; Deltaretrovirus - metabolism ; Demographics ; Denmark ; Hemophilia A - microbiology ; HIV ; HIV infections ; Homosexuality ; Humans ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Infections ; Kaposi sarcoma ; Male ; Male homosexuality ; Medical research ; Medical sciences ; Men ; New York City ; Risk ; Sarcoma, Kaposi - microbiology ; Time Factors ; United States ; Viruses</subject><ispartof>Science (American Association for the Advancement of Science), 1986-02, Vol.231 (4741), p.992-995</ispartof><rights>Copyright 1986 The American Association for the Advancement of Science</rights><rights>1987 INIST-CNRS</rights><rights>Copyright American Association for the Advancement of Science Feb 28, 1986</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c407t-bc42309981cf20859b88dbba5c5969f0752b8a3a6fe2a768ffbfb9318c9a58963</citedby><cites>FETCH-LOGICAL-c407t-bc42309981cf20859b88dbba5c5969f0752b8a3a6fe2a768ffbfb9318c9a58963</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/1696964$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/1696964$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,2884,2885,27924,27925,58017,58250</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7887113$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3003917$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Goedert, James J.</creatorcontrib><creatorcontrib>Biggar, Robert J.</creatorcontrib><creatorcontrib>Weiss, Stanley H.</creatorcontrib><creatorcontrib>Eyster, M. Elaine</creatorcontrib><creatorcontrib>Melbye, Mads</creatorcontrib><creatorcontrib>Wilson, Susan</creatorcontrib><creatorcontrib>Ginzburg, Harold M.</creatorcontrib><creatorcontrib>Grossman, Ronald J.</creatorcontrib><creatorcontrib>DiGioia, Richard A.</creatorcontrib><creatorcontrib>Sanchez, William C.</creatorcontrib><creatorcontrib>Giron, José A.</creatorcontrib><creatorcontrib>Ebbesen, Peter</creatorcontrib><creatorcontrib>Gallo, Robert C.</creatorcontrib><creatorcontrib>Blattner, William A.</creatorcontrib><title>Three-Year Incidence of AIDS in Five Cohorts of HTLV-III-Infected Risk Group Members</title><title>Science (American Association for the Advancement of Science)</title><addtitle>Science</addtitle><description>The incidence of the acquired immune deficiency syndrome (AIDS) among persons infected with human T-lymphotropic virus type III (HTLV-III) was evaluated prospectively among 725 persons who were at high risk of AIDS and had enrolled before October 1982 in cohort studies of homosexual men, parenteral drug users, and hemophiliacs. A total of 276 (38.1 percent) of the subjects were either HTLV-III seropositive at enrollment or developed HTLV-III antibodies subsequently. AIDS had developed in 28 (10.1 percent) of the seropositive subjects before August 1985. By actuarial survival calculations, the 3-year incidence of AIDS among all HTLV-III seropositive subjects was 34.2 percent in the cohort of homosexual men in Manhattan, New York, and 14.9 percent (range 8.0 to 17.2 percent) in the four other cohorts. Out of 117 subjects followed for a mean of 31 months after documented seroconversion, five (all hemophiliacs) developed AIDS 28 to 62 months after the estimated date of seroconversion, supporting the hypothesis that there is a long latency between acquisition of viral infection and the development of clinical AIDS. This long latency could account for the significantly higher AIDS incidence in the New York cohort compared with other cohorts if the virus entered the New York homosexual population before it entered the populations from which the other cohorts were drawn. However, risk of AIDS development in different populations may also depend on the presence of as yet unidentified cofactors.</description><subject>Acquired immune deficiency syndrome</subject><subject>Acquired Immunodeficiency Syndrome - microbiology</subject><subject>Acquired Immunodeficiency Syndrome - physiopathology</subject><subject>Acquired Immunodeficiency Syndrome - transmission</subject><subject>AIDS</subject><subject>AIDS/HIV</subject><subject>Antibodies</subject><subject>Antibodies, Viral - analysis</subject><subject>Biological and medical sciences</subject><subject>Deltaretrovirus - metabolism</subject><subject>Demographics</subject><subject>Denmark</subject><subject>Hemophilia A - microbiology</subject><subject>HIV</subject><subject>HIV infections</subject><subject>Homosexuality</subject><subject>Humans</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Infections</subject><subject>Kaposi sarcoma</subject><subject>Male</subject><subject>Male homosexuality</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Men</subject><subject>New York City</subject><subject>Risk</subject><subject>Sarcoma, Kaposi - microbiology</subject><subject>Time Factors</subject><subject>United States</subject><subject>Viruses</subject><issn>0036-8075</issn><issn>1095-9203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkctrGzEQxkVpSJyk515aECXktokeu3ocg5vHgkMgdQs9LZI8IuvYK1faLeS_j4yXBHLxaWC-n74ZzYfQV0ouKGXiMrkWOgcXnBCuqfyEJpToqtCM8M9okpuiUERWR-g4pSUhWdP8EB2O-ATN508RoPgLJuK6c-1i64aDx1f1z1-47fBN-x_wNDyF2Kdt_24--1PUdV3UnQfXwwI_tukZ38YwbPA9rC3EdIoOvFkl-DLWE_T75no-vStmD7f19GpWuJLIvrCuZJxorajzjKhKW6UW1prKVVpon9dmVhluhAdmpFDeW281p8ppUykt-Ak63_luYvg3QOqbdZscrFamgzCkRgpJOM8_3gdywVQ-yH5HRqmsZFnuBWlZloIxmsEfH8BlGGKXz5LNeMWE1Fvocge5GFKK4JtNbNcmvjSUNNucmzHnZgwuv_g-2g52DYs3_l0_G3WTnFn5aHK46Q2TSklKeca-7bBl6kN8nypyAKLkr7n-tss</recordid><startdate>19860228</startdate><enddate>19860228</enddate><creator>Goedert, James J.</creator><creator>Biggar, Robert J.</creator><creator>Weiss, Stanley H.</creator><creator>Eyster, M. Elaine</creator><creator>Melbye, Mads</creator><creator>Wilson, Susan</creator><creator>Ginzburg, Harold M.</creator><creator>Grossman, Ronald J.</creator><creator>DiGioia, Richard A.</creator><creator>Sanchez, William C.</creator><creator>Giron, José A.</creator><creator>Ebbesen, Peter</creator><creator>Gallo, Robert C.</creator><creator>Blattner, William A.</creator><general>The American Association for the Advancement of Science</general><general>American Association for the Advancement of Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QF</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QQ</scope><scope>7QR</scope><scope>7SC</scope><scope>7SE</scope><scope>7SN</scope><scope>7SP</scope><scope>7SR</scope><scope>7SS</scope><scope>7T7</scope><scope>7TA</scope><scope>7TB</scope><scope>7TK</scope><scope>7TM</scope><scope>7U5</scope><scope>7U9</scope><scope>8BQ</scope><scope>8FD</scope><scope>C1K</scope><scope>F28</scope><scope>FR3</scope><scope>H8D</scope><scope>H8G</scope><scope>H94</scope><scope>JG9</scope><scope>JQ2</scope><scope>K9.</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>19860228</creationdate><title>Three-Year Incidence of AIDS in Five Cohorts of HTLV-III-Infected Risk Group Members</title><author>Goedert, James J. ; Biggar, Robert J. ; Weiss, Stanley H. ; Eyster, M. Elaine ; Melbye, Mads ; Wilson, Susan ; Ginzburg, Harold M. ; Grossman, Ronald J. ; DiGioia, Richard A. ; Sanchez, William C. ; Giron, José A. ; Ebbesen, Peter ; Gallo, Robert C. ; Blattner, William A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c407t-bc42309981cf20859b88dbba5c5969f0752b8a3a6fe2a768ffbfb9318c9a58963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Acquired Immunodeficiency Syndrome - microbiology</topic><topic>Acquired Immunodeficiency Syndrome - physiopathology</topic><topic>Acquired Immunodeficiency Syndrome - transmission</topic><topic>AIDS</topic><topic>AIDS/HIV</topic><topic>Antibodies</topic><topic>Antibodies, Viral - analysis</topic><topic>Biological and medical sciences</topic><topic>Deltaretrovirus - metabolism</topic><topic>Demographics</topic><topic>Denmark</topic><topic>Hemophilia A - microbiology</topic><topic>HIV</topic><topic>HIV infections</topic><topic>Homosexuality</topic><topic>Humans</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Infections</topic><topic>Kaposi sarcoma</topic><topic>Male</topic><topic>Male homosexuality</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Men</topic><topic>New York City</topic><topic>Risk</topic><topic>Sarcoma, Kaposi - microbiology</topic><topic>Time Factors</topic><topic>United States</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Goedert, James J.</creatorcontrib><creatorcontrib>Biggar, Robert J.</creatorcontrib><creatorcontrib>Weiss, Stanley H.</creatorcontrib><creatorcontrib>Eyster, M. Elaine</creatorcontrib><creatorcontrib>Melbye, Mads</creatorcontrib><creatorcontrib>Wilson, Susan</creatorcontrib><creatorcontrib>Ginzburg, Harold M.</creatorcontrib><creatorcontrib>Grossman, Ronald J.</creatorcontrib><creatorcontrib>DiGioia, Richard A.</creatorcontrib><creatorcontrib>Sanchez, William C.</creatorcontrib><creatorcontrib>Giron, José A.</creatorcontrib><creatorcontrib>Ebbesen, Peter</creatorcontrib><creatorcontrib>Gallo, Robert C.</creatorcontrib><creatorcontrib>Blattner, William A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Aluminium Industry Abstracts</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Ecology Abstracts</collection><collection>Electronics &amp; Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Materials Business File</collection><collection>Mechanical &amp; Transportation Engineering Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ANTE: Abstracts in New Technology &amp; Engineering</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>Copper Technical Reference Library</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts – Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Science (American Association for the Advancement of Science)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Goedert, James J.</au><au>Biggar, Robert J.</au><au>Weiss, Stanley H.</au><au>Eyster, M. Elaine</au><au>Melbye, Mads</au><au>Wilson, Susan</au><au>Ginzburg, Harold M.</au><au>Grossman, Ronald J.</au><au>DiGioia, Richard A.</au><au>Sanchez, William C.</au><au>Giron, José A.</au><au>Ebbesen, Peter</au><au>Gallo, Robert C.</au><au>Blattner, William A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Three-Year Incidence of AIDS in Five Cohorts of HTLV-III-Infected Risk Group Members</atitle><jtitle>Science (American Association for the Advancement of Science)</jtitle><addtitle>Science</addtitle><date>1986-02-28</date><risdate>1986</risdate><volume>231</volume><issue>4741</issue><spage>992</spage><epage>995</epage><pages>992-995</pages><issn>0036-8075</issn><eissn>1095-9203</eissn><coden>SCIEAS</coden><abstract>The incidence of the acquired immune deficiency syndrome (AIDS) among persons infected with human T-lymphotropic virus type III (HTLV-III) was evaluated prospectively among 725 persons who were at high risk of AIDS and had enrolled before October 1982 in cohort studies of homosexual men, parenteral drug users, and hemophiliacs. A total of 276 (38.1 percent) of the subjects were either HTLV-III seropositive at enrollment or developed HTLV-III antibodies subsequently. AIDS had developed in 28 (10.1 percent) of the seropositive subjects before August 1985. By actuarial survival calculations, the 3-year incidence of AIDS among all HTLV-III seropositive subjects was 34.2 percent in the cohort of homosexual men in Manhattan, New York, and 14.9 percent (range 8.0 to 17.2 percent) in the four other cohorts. Out of 117 subjects followed for a mean of 31 months after documented seroconversion, five (all hemophiliacs) developed AIDS 28 to 62 months after the estimated date of seroconversion, supporting the hypothesis that there is a long latency between acquisition of viral infection and the development of clinical AIDS. This long latency could account for the significantly higher AIDS incidence in the New York cohort compared with other cohorts if the virus entered the New York homosexual population before it entered the populations from which the other cohorts were drawn. However, risk of AIDS development in different populations may also depend on the presence of as yet unidentified cofactors.</abstract><cop>Washington, DC</cop><pub>The American Association for the Advancement of Science</pub><pmid>3003917</pmid><doi>10.1126/science.3003917</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0036-8075
ispartof Science (American Association for the Advancement of Science), 1986-02, Vol.231 (4741), p.992-995
issn 0036-8075
1095-9203
language eng
recordid cdi_proquest_miscellaneous_76703359
source MEDLINE; JSTOR Archive Collection A-Z Listing; American Association for the Advancement of Science
subjects Acquired immune deficiency syndrome
Acquired Immunodeficiency Syndrome - microbiology
Acquired Immunodeficiency Syndrome - physiopathology
Acquired Immunodeficiency Syndrome - transmission
AIDS
AIDS/HIV
Antibodies
Antibodies, Viral - analysis
Biological and medical sciences
Deltaretrovirus - metabolism
Demographics
Denmark
Hemophilia A - microbiology
HIV
HIV infections
Homosexuality
Humans
Immunodeficiencies
Immunodeficiencies. Immunoglobulinopathies
Immunopathology
Infections
Kaposi sarcoma
Male
Male homosexuality
Medical research
Medical sciences
Men
New York City
Risk
Sarcoma, Kaposi - microbiology
Time Factors
United States
Viruses
title Three-Year Incidence of AIDS in Five Cohorts of HTLV-III-Infected Risk Group Members
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T05%3A04%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Three-Year%20Incidence%20of%20AIDS%20in%20Five%20Cohorts%20of%20HTLV-III-Infected%20Risk%20Group%20Members&rft.jtitle=Science%20(American%20Association%20for%20the%20Advancement%20of%20Science)&rft.au=Goedert,%20James%20J.&rft.date=1986-02-28&rft.volume=231&rft.issue=4741&rft.spage=992&rft.epage=995&rft.pages=992-995&rft.issn=0036-8075&rft.eissn=1095-9203&rft.coden=SCIEAS&rft_id=info:doi/10.1126/science.3003917&rft_dat=%3Cjstor_proqu%3E1696964%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=213526791&rft_id=info:pmid/3003917&rft_jstor_id=1696964&rfr_iscdi=true